Our mission is to become a worldwide reference for education in the field for all professionals involved in the process to disseminate knowledge & skills of Acute Cardiovascular Care.
Our mission is to promote excellence in clinical diagnosis, research, technical development, and education in cardiovascular imaging in Europe.
Our mission is to promote excellence in research, practice, education and policy in cardiovascular health, primary and secondary prevention.
Our mission is to reduce the burden of cardiovascular disease in Europe through percutaneous cardiovascular interventions.
Our mission is to improve the quality of life of the population by reducing the impact of cardiac rhythm disturbances and reduce sudden cardiac death.
Our mission is to improve quality of life and longevity, through better prevention, diagnosis and treatment of heart failure, including the establishment of networks for its management, education and research.
The ESC Working Groups' goal is to stimulate and disseminate scientific knowledge in different fields of cardiology.
The ESC Councils' goal is to share knowledge among medical professionals practising in specific cardiology domains.
OUR MISSION: TO REDUCE THE BURDEN OF CARDIOVASCULAR DISEASE
New ESC journal aims to publish the highest quality research, interpreting and integrating new scientific developments within the field of cardiovascular pharmacotherapy.
Sophia Antipolis, 22 January 2015. The European Society of Cardiology is delighted to announce the publication of the first issue of European Heart Journal – Cardiovascular Pharmacotherapy (EHJCVP), which will be published by Oxford University Press (OUP).Pharmacotherapy is an increasingly important area of cardiology given the high number of cardiac patients who are on medication of some kind. This new journal aims to publish the highest quality research, interpreting and integrating new scientific developments within the field of cardiovascular pharmacotherapy. The overarching goal of the journal is to improve the care of patients with cardiovascular disease with a specific focus on cardiovascular pharmacotherapy.Professor Fausto Pinto, President of the ESC said:
"The ESC is very proud to launch this new journal that will address a gap in cardiovascular publications today. Updated information on new treatment strategies is essential for today's practices and better patient management. I am certain that this new member of the ESC journal family will be very useful and well received by the cardiovascular community."
Helen Leipman, Senior Publisher at OUP said:
“Oxford University Press is very proud to be involved in this new initiative of the ESC as publisher of their new journal. The field of clinical cardiovascular pharmacology is a burgeoning one but it is ever important to focus on improving prognosis for cardiovascular disease and we hope that we can go some way to achieving that with the new journal. Alongside European Heart Journal and Cardiovascular Research, EHJ-Cardiovascular Pharmacotherapy is an important addition to the ESC journal family and we look forward to working with Professor Agewall and his team to make it a great success.”
The Editor-in-Chief of EHJCVP is Professor Stefan Agewall of the Institute for Clinical Medicine at the University of Oslo. OUP will publish four issues of EHJCVP in 2015, and the journal will be freely available until December 2016. Ends
The European Society of Cardiology (ESC) represents more than 80 000 cardiology professionals across Europe and the Mediterranean. Its mission is to reduce the burden of cardiovascular disease in Europe.
Oxford Journals is part of Oxford University Press. We publish well over 230 academic and research journals covering a broad range of subject areas, two-thirds of which are published in collaboration with learned societies and other international organizations. We have been publishing journals for more than a century, and as part of the world’s oldest and largest university press, have more than 500 years of publishing expertise behind us. Follow Oxford Journals on Twitter: @OxfordJournals
© 2017 European Society of Cardiology. All rights reserved